why is moderna stock down so much

Heres a quick rundown of the. Shares of Moderna MRNA -288 fell 9 on Wednesday after Scandinavian health officials said they would take action to limit the use of the drugmakers COVID-19 vaccine in children and young.

Oil And Stock Markets Hit By Omicron Worries And Fears Of Faster Fed Tapering As It Happened Business The Guardian

Since then its stock has soared 325.

. Get the latest Moderna stock price and detailed information including MRNA news historical charts and realtime prices. This concern came to the surface on Tuesday. Positive news from a top.

Lets talk about why. Positive news from a top rival was a key reason why. Moderna Stock Drops As Skepticism About Future Vaccine Sales Grows.

Although it wasnt down by as much as the SP 500 index Moderna was still off by almost 2 in late afternoon trading. Here are three reasons why Modernas stock is coming down to earth. Although its the best performing SP 500 stock this year dont expect more gains.

Over the past week though the stock has plummeted. MRNA stock rose by about 4 over the last week to levels of around 113 per share. The company has managed to put together strong sales growth.

Shares of Moderna gained downside momentum after the FDA postponed a meeting on the authorization of Pfizer BioNTech vaccine. News that a pair of large and important customers have declined to exercise options for more Spikevax doses sent Moderna shares down by slightly more. Moderna stock isnt a buy right now.

Shares arent forming a definitive chart pattern. Moderna Stock Falls Amid Broad Sell-Off. Shares of Moderna are down by 7 today as higher Treasury yields put significant pressure on high-growth stocks.

There is a broad sell-off in the market. So Is Moderna Stock A Buy Or Sell Right Now. In November 2020 I estimated that its Covid-19 vaccine now branded SpikeVax -- could add as much as 35 billion to Modernas revenues.

Moderna stock currently trades at 326 per share and many analysts agree its overvalued. Investors rewarded it handsomely sending the market capitalization of a company with no approved product to over 30 billion. After hitting a high of 9485 on July 17 Modernas stock has now fallen by about 25.

Moderna Biontech Lose 60 Billion In Value In Two Day Drop Bloomberg